Shanghai RAAS Blood Products Co Ltd banner

Shanghai RAAS Blood Products Co Ltd
SZSE:002252

Watchlist Manager
Shanghai RAAS Blood Products Co Ltd Logo
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
Watchlist
Price: 5.74 CNY 0.88% Market Closed
Market Cap: ¥38.1B

Income Statement

Earnings Waterfall
Shanghai RAAS Blood Products Co Ltd

Income Statement
Shanghai RAAS Blood Products Co Ltd

Rotate your device to view
Income Statement
Currency: CNY
Dec-2007 Mar-2008 Jun-2008 Sep-2008 Dec-2008 Mar-2009 Jun-2009 Sep-2009 Dec-2009 Mar-2010 Jun-2010 Sep-2010 Dec-2010 Mar-2011 Jun-2011 Sep-2011 Dec-2011 Mar-2012 Jun-2012 Sep-2012 Dec-2012 Mar-2013 Jun-2013 Sep-2013 Dec-2013 Mar-2014 Jun-2014 Sep-2014 Dec-2014 Mar-2015 Jun-2015 Sep-2015 Dec-2015 Mar-2016 Jun-2016 Sep-2016 Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024 Dec-2024 Mar-2025 Jun-2025 Sep-2025 Dec-2025
Revenue
Interest Expense
4
0
0
0
3
0
0
0
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
16
0
0
0
24
0
0
0
22
0
0
0
35
0
0
17
70
0
0
37
66
20
20
4
2
1
1
0
0
0
1
1
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
44
Revenue
310
N/A
296
-4%
319
+8%
323
+1%
310
-4%
291
-6%
296
+2%
319
+8%
388
+22%
390
+1%
414
+6%
473
+14%
483
+2%
488
+1%
521
+7%
534
+3%
567
+6%
563
-1%
578
+3%
606
+5%
663
+9%
685
+3%
720
+5%
705
-2%
496
-30%
657
+32%
744
+13%
860
+16%
1 320
+54%
1 422
+8%
1 594
+12%
1 986
+25%
2 013
+1%
2 144
+6%
2 235
+4%
2 138
-4%
2 326
+9%
2 241
-4%
2 155
-4%
2 177
+1%
1 928
-11%
1 844
-4%
2 021
+10%
1 869
-8%
1 804
-3%
2 072
+15%
2 141
+3%
2 311
+8%
2 585
+12%
2 732
+6%
2 597
-5%
2 707
+4%
2 762
+2%
2 884
+4%
3 208
+11%
3 770
+18%
4 288
+14%
5 119
+19%
5 826
+14%
6 193
+6%
6 567
+6%
6 945
+6%
7 174
+3%
7 551
+5%
7 964
+5%
7 957
0%
8 316
+5%
8 343
+0%
8 176
-2%
8 126
-1%
7 876
-3%
7 953
+1%
7 348
-8%
Gross Profit
Cost of Revenue
(140)
(115)
(120)
(120)
(117)
(118)
(121)
(138)
(166)
(160)
(168)
(183)
(182)
(190)
(209)
(222)
(241)
(242)
(251)
(254)
(262)
(281)
(284)
(274)
(175)
(257)
(290)
(327)
(494)
(534)
(593)
(753)
(777)
(780)
(832)
(795)
(845)
(861)
(829)
(821)
(706)
(676)
(708)
(655)
(617)
(717)
(765)
(824)
(936)
(996)
(928)
(1 022)
(1 060)
(1 175)
(1 374)
(1 725)
(2 069)
(2 649)
(3 165)
(3 403)
(3 678)
(3 947)
(4 122)
(4 437)
(4 735)
(4 837)
(5 037)
(5 067)
(4 872)
(4 895)
(4 850)
(4 986)
(4 658)
Gross Profit
170
N/A
181
+7%
199
+10%
203
+2%
193
-5%
173
-10%
176
+1%
181
+3%
222
+22%
230
+4%
246
+7%
290
+18%
301
+4%
298
-1%
311
+4%
312
+0%
327
+5%
321
-2%
327
+2%
352
+8%
401
+14%
404
+1%
435
+8%
431
-1%
321
-26%
399
+24%
454
+14%
533
+17%
825
+55%
888
+8%
1 001
+13%
1 233
+23%
1 236
+0%
1 364
+10%
1 403
+3%
1 344
-4%
1 482
+10%
1 380
-7%
1 326
-4%
1 356
+2%
1 222
-10%
1 168
-4%
1 313
+12%
1 214
-8%
1 187
-2%
1 354
+14%
1 376
+2%
1 487
+8%
1 649
+11%
1 737
+5%
1 669
-4%
1 685
+1%
1 702
+1%
1 710
+0%
1 835
+7%
2 045
+11%
2 219
+8%
2 470
+11%
2 660
+8%
2 789
+5%
2 889
+4%
2 998
+4%
3 052
+2%
3 114
+2%
3 229
+4%
3 120
-3%
3 279
+5%
3 276
0%
3 304
+1%
3 231
-2%
3 026
-6%
2 967
-2%
2 690
-9%
Operating Income
Operating Expenses
(63)
(57)
(60)
(67)
(65)
(64)
(70)
(70)
(73)
(77)
(75)
(90)
(91)
(90)
(93)
(83)
(99)
(96)
(116)
(123)
(145)
(144)
(147)
(151)
(141)
(159)
(163)
(175)
(242)
(259)
(290)
(330)
(395)
(384)
(385)
(386)
(380)
(359)
(404)
(434)
(325)
(453)
(447)
(497)
(720)
(956)
(1 029)
(1 036)
(785)
(890)
(823)
(802)
(643)
(783)
(803)
(854)
(730)
(1 134)
(1 195)
(1 225)
(886)
(1 076)
(1 091)
(1 091)
(897)
(845)
(954)
(979)
(1 170)
(1 161)
(1 096)
(1 162)
(1 099)
Selling, General & Administrative
(57)
(57)
(61)
(66)
(66)
(65)
(68)
(70)
(73)
(77)
(76)
(90)
(90)
(90)
(92)
(82)
(97)
(94)
(115)
(122)
(117)
(141)
(141)
(145)
(111)
(154)
(160)
(175)
(180)
(259)
(285)
(322)
(267)
(370)
(372)
(365)
(274)
(353)
(372)
(373)
(316)
(382)
(415)
(493)
(603)
(632)
(683)
(682)
(651)
(666)
(605)
(582)
(495)
(555)
(575)
(611)
(579)
(647)
(694)
(716)
(713)
(725)
(723)
(716)
(713)
(702)
(781)
(771)
(921)
(918)
(840)
(918)
(819)
Research & Development
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(24)
0
0
0
(22)
0
0
0
(46)
0
0
0
(101)
0
0
0
(77)
0
0
(26)
(97)
0
0
(47)
(92)
(78)
(102)
(107)
(97)
(99)
(99)
(104)
(125)
(130)
(129)
(138)
(122)
(142)
(149)
(153)
(140)
(157)
(168)
(176)
(169)
(178)
(193)
(232)
(245)
(234)
(246)
(210)
(216)
Depreciation & Amortization
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(5)
0
0
0
(7)
0
0
0
(18)
0
0
0
(27)
0
0
0
(30)
0
0
0
53
0
0
0
(57)
0
0
0
(62)
0
0
0
(63)
0
0
0
(57)
0
0
0
(48)
0
0
0
(37)
0
0
0
(46)
0
0
0
(71)
Other Operating Expenses
(6)
(0)
0
(0)
1
0
(2)
(0)
(0)
0
1
(1)
(1)
0
(1)
(1)
(2)
(2)
(2)
(2)
0
(3)
(6)
(6)
(2)
(6)
(3)
(0)
2
1
(5)
(9)
(0)
(15)
(14)
(21)
(0)
(7)
(32)
(35)
35
(71)
(33)
43
32
(246)
(244)
(248)
26
(125)
(119)
(116)
40
(98)
(100)
(105)
28
(345)
(353)
(355)
16
(194)
(199)
(199)
22
34
20
24
43
(9)
(10)
(33)
8
Operating Income
107
N/A
124
+16%
139
+12%
137
-1%
128
-7%
110
-14%
105
-4%
111
+5%
148
+34%
153
+3%
171
+12%
200
+17%
211
+5%
208
-1%
218
+5%
229
+5%
228
0%
225
-1%
211
-6%
229
+8%
256
+12%
260
+2%
289
+11%
281
-3%
180
-36%
240
+33%
291
+21%
358
+23%
583
+63%
630
+8%
711
+13%
903
+27%
841
-7%
980
+17%
1 018
+4%
957
-6%
1 102
+15%
1 020
-7%
922
-10%
922
+0%
898
-3%
714
-20%
866
+21%
717
-17%
467
-35%
399
-15%
346
-13%
451
+30%
864
+92%
847
-2%
847
+0%
883
+4%
1 059
+20%
927
-13%
1 031
+11%
1 191
+15%
1 489
+25%
1 335
-10%
1 465
+10%
1 565
+7%
2 004
+28%
1 921
-4%
1 961
+2%
2 022
+3%
2 332
+15%
2 274
-2%
2 325
+2%
2 297
-1%
2 134
-7%
2 070
-3%
1 929
-7%
1 805
-6%
1 591
-12%
Pre-Tax Income
Interest Income Expense
(7)
(7)
(8)
(7)
(2)
1
3
12
11
11
11
7
7
8
9
6
7
7
7
5
5
3
(5)
(10)
(13)
(22)
(20)
11
16
345
680
718
888
666
504
870
846
806
1 061
638
110
(759)
(1 672)
(2 337)
(2 032)
(1 085)
(621)
36
11
1
211
391
571
676
684
642
434
388
328
302
472
554
511
471
(102)
26
(8)
75
549
371
428
360
395
Non-Reccuring Items
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(187)
(0)
0
1
(140)
4
6
5
(132)
0
(2)
(2)
(372)
(1)
(0)
(0)
(199)
0
0
0
(7)
(1)
(1)
(2)
(15)
(0)
(0)
(0)
(76)
Gain/Loss on Disposition of Assets
(3)
0
0
0
(1)
0
0
0
(0)
0
0
0
0
0
0
0
(0)
0
0
0
(0)
0
0
0
(0)
0
(0)
0
(1)
(1)
0
(1)
(0)
(0)
(0)
(1)
0
0
(0)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Total Other Income
1
(3)
(4)
(5)
(0)
(1)
1
2
1
0
2
2
3
4
2
2
1
2
3
5
4
3
3
2
2
2
1
0
4
5
8
18
20
29
22
12
11
18
19
18
(3)
(20)
(18)
(17)
(4)
(5)
(5)
(5)
(2)
(13)
(26)
(26)
(22)
(15)
(2)
(15)
(13)
(14)
(14)
(2)
(3)
(6)
(8)
(12)
(18)
(33)
(97)
(111)
(48)
(54)
3
15
(5)
Pre-Tax Income
98
N/A
114
+16%
127
+12%
125
-2%
125
0%
110
-12%
109
0%
124
+14%
160
+28%
164
+3%
184
+12%
209
+14%
221
+6%
220
-1%
230
+5%
236
+3%
236
0%
234
-1%
221
-6%
239
+8%
265
+11%
266
+0%
286
+8%
273
-5%
169
-38%
221
+31%
272
+23%
369
+36%
602
+63%
978
+63%
1 399
+43%
1 638
+17%
1 749
+7%
1 675
-4%
1 543
-8%
1 838
+19%
1 959
+7%
1 844
-6%
2 002
+9%
1 579
-21%
1 005
-36%
(65)
N/A
(823)
-1 165%
(1 637)
-99%
(1 756)
-7%
(691)
+61%
(279)
+60%
483
N/A
733
+52%
839
+14%
1 038
+24%
1 254
+21%
1 477
+18%
1 588
+7%
1 711
+8%
1 815
+6%
1 539
-15%
1 709
+11%
1 778
+4%
1 864
+5%
2 274
+22%
2 469
+9%
2 465
0%
2 482
+1%
2 204
-11%
2 266
+3%
2 219
-2%
2 260
+2%
2 620
+16%
2 387
-9%
2 360
-1%
2 180
-8%
1 906
-13%
Net Income
Tax Provision
(16)
(21)
(23)
(25)
(19)
(16)
(16)
(18)
(23)
(26)
(28)
(32)
(36)
(33)
(35)
(36)
(36)
(36)
(34)
(36)
(41)
(41)
(44)
(43)
(27)
(35)
(42)
(56)
(92)
(149)
(212)
(249)
(269)
(257)
(242)
(288)
(309)
(295)
(315)
(255)
(173)
(15)
98
235
233
77
18
(106)
(127)
(142)
(150)
(160)
(159)
(153)
(178)
(197)
(250)
(298)
(340)
(368)
(401)
(424)
(412)
(423)
(427)
(450)
(438)
(430)
(426)
(384)
(378)
(355)
(329)
Income from Continuing Operations
82
94
104
101
105
94
93
107
137
138
156
177
185
186
194
200
200
199
187
202
224
225
242
230
143
186
230
313
511
829
1 187
1 389
1 480
1 418
1 302
1 550
1 650
1 549
1 687
1 323
832
(80)
(726)
(1 402)
(1 523)
(614)
(261)
377
606
697
888
1 094
1 319
1 434
1 533
1 619
1 289
1 410
1 438
1 496
1 873
2 045
2 053
2 059
1 777
1 816
1 781
1 830
2 194
2 003
1 982
1 826
1 577
Income to Minority Interest
0
0
0
(0)
(0)
(1)
(1)
(2)
(1)
(1)
(1)
(0)
0
0
1
1
1
1
1
1
1
1
1
2
1
1
2
1
0
(6)
(18)
(30)
(38)
(42)
(42)
(42)
(37)
(26)
(14)
(4)
4
4
6
5
5
4
3
4
2
3
4
4
5
5
4
5
6
6
7
6
7
5
5
5
2
1
1
(1)
(0)
(0)
0
1
0
Net Income (Common)
82
N/A
94
+15%
104
+11%
100
-4%
105
+5%
93
-11%
92
-1%
105
+14%
136
+29%
137
+1%
155
+13%
177
+14%
186
+5%
186
+0%
195
+5%
201
+3%
200
0%
199
0%
188
-6%
203
+8%
225
+11%
226
+0%
244
+8%
231
-5%
144
-38%
188
+30%
232
+23%
315
+36%
511
+62%
823
+61%
1 169
+42%
1 359
+16%
1 442
+6%
1 376
-5%
1 259
-8%
1 508
+20%
1 613
+7%
1 523
-6%
1 673
+10%
1 320
-21%
836
-37%
(76)
N/A
(720)
-851%
(1 397)
-94%
(1 518)
-9%
(610)
+60%
(258)
+58%
380
N/A
608
+60%
700
+15%
892
+27%
1 098
+23%
1 324
+21%
1 439
+9%
1 537
+7%
1 624
+6%
1 295
-20%
1 416
+9%
1 445
+2%
1 502
+4%
1 880
+25%
2 051
+9%
2 058
+0%
2 064
+0%
1 779
-14%
1 818
+2%
1 781
-2%
1 830
+3%
2 193
+20%
2 003
-9%
1 982
-1%
1 826
-8%
1 577
-14%
EPS (Diluted)
0.02
N/A
0.04
+100%
0.04
N/A
0.04
N/A
0.03
-25%
0.04
+33%
0.04
N/A
0.04
N/A
0.04
N/A
0.04
N/A
0.04
N/A
0.05
+25%
0.05
N/A
0.06
+20%
0.07
+17%
0.07
N/A
0.06
-14%
0.07
+17%
0.06
-14%
0.06
N/A
0.06
N/A
0.06
N/A
0.07
+17%
0.07
N/A
0.04
-43%
0.06
+50%
0.06
N/A
0.07
+17%
0.1
+43%
0.17
+70%
0.24
+41%
0.28
+17%
0.29
+4%
0.28
-3%
0.26
-7%
0.31
+19%
0.32
+3%
0.31
-3%
0.34
+10%
0.27
-21%
0.17
-37%
-0.01
N/A
-0.14
-1 300%
-0.28
-100%
-0.31
-11%
-0.13
+58%
-0.06
+54%
0.07
N/A
0.12
+71%
0.14
+17%
0.13
-7%
0.18
+38%
0.21
+17%
0.22
+5%
0.23
+5%
0.24
+4%
0.19
-21%
0.21
+11%
0.21
N/A
0.22
+5%
0.28
+27%
0.3
+7%
0.31
+3%
0.31
N/A
0.27
-13%
0.27
N/A
0.27
N/A
0.28
+4%
0.33
+18%
0.3
-9%
0.3
N/A
0.27
-10%
0.24
-11%
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett